Aromatase Inhibitors

Kristy Brown

Aromatase Inhibitors are a class of drugs used in the treatment of hormone receptor positive breast and ovarian cancers in post- menopausal women. Kristy Brown, Co-Head, Metabolism & Cancer Laboratory, Prince Henry’s Institute is a researcher with a particular interest in the Aromatase Inhibitors. Kristy will speak about the different types of Aromatase Inhibitors, how they work, their benefits and side effects and recent developments in their use.

Listen to the audio from this session:

Download the file

Last Updated: 8 September, 2015 4:20 pm